ABAK's Website Loading
To promote the role of the alcohol industry as a trusted partner to the government, consumers, value chain players and society towards responsible, safe and controlled consumption of alcohol.
2009年8月FDA針對服用120毫克Orlistat及60毫克非處方藥Orlistat,進行全面審查及檢討,結果確定共有13例嚴重肝損傷個案,減肥藥,必須在其標籤加註,有12人服用120毫克Orlistat,1人服用60毫克Orlistat,而13例中,有2例死於肝衰竭,共3例需要肝臟移植手術。